Ascend Laboratories LLC: Drug Recall
Recall #D-0229-2022 · 11/03/2021
Class II: Risk
Recall Details
- Recall Number
- D-0229-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- Ascend Laboratories LLC
- Status
- Terminated
- Date Initiated
- 11/03/2021
- Location
- Parsippany, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4104 bottles
Reason for Recall
Failed Impurities/Degradation Specifications
Product Description
Cefixime Capsules 400 mg, 50 capsules bottles, Rx Only, Manufactured by: Alken Laboratories Ltd., Mumbai - 400 013, India, Distributed by: Ascend Laboratories LLC, Parsippany, NJ, 07054 NDC 67877-584-50
Distribution Pattern
Nationwide
Other Recalls by Ascend Laboratories LLC
- Class II: Risk 09/19/2025
- Class II: Risk 09/19/2025
- Class II: Risk 09/19/2025
- Class II: Risk 09/19/2025
- Class II: Risk 08/28/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.